Fairvalue-Calculator Fairvalue-Calculator
EN DE

PT Phapros Tbk, (PEHA) Fair Value & Analysis

Healthcare · ID · Market cap 183B IDR

Price278.00 IDR
Fair Value734.16 IDR
Upside+164.1%
Quality94/100
Evidence: High Range 409.55 IDR – 917.69 IDR

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

PT Phapros Tbk, (PEHA) currently trades at 278.00 IDR, while our model-based Fair Value estimate is 734.16 IDR — implying the stock looks roughly 164.1% undervalued today. We read business quality at 94/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also provides ethical generic and branded products; and medical devices, as well as toll manufacturing. It also exports its products. The company was founded in 1954 and is headquartered in Jakarta Selatan, Indonesia. PT Phapros Tbk is a subsidiary of PT Kimia Farma Tbk.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1827% Jiangsu Hengrui Pharmaceuticals Co (600276) -43% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -24% Hansoh Pharmaceutical Group (3692) -18% United Therapeutics Corporation (U2TH34) -6%

Frequently asked questions

Is PT Phapros Tbk, (PEHA) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 734.16 IDR versus a price of 278.00 IDR — about +164% (undervalued). Model-based estimate, not financial advice.
What is the fair value of PEHA?
Our 21-model fair value for PT Phapros Tbk, is 734.16 IDR (as of Jun 25, 2026), built from audited fundamentals. The current price is 278.00 IDR.
What is the quality score of PEHA?
PT Phapros Tbk, has a Quality Score of 94/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.